EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Ecarin-based coagulation monitoring of argatroban in patients with heparin-induced thrombocytopenia: a prospective observational study

Arno Schiferer, Christine Schlömmer, Georg Scheriau, Daniela Boryshchuk, Elias L Meyer, Sebastian Benque, Caroline Holaubek, Pedro Wendel-Garcia, Barbara Steinlechner

British Journal of Anaesthesia · 2026

DOI: 10.1016/j.bja.2025.08.065 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift British Journal of Anaesthesia, 2026. Verfasst von Arno Schiferer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesia, Intensive Care Medicine and Pain Medicine, Division of Cardio-Thoracic-Vascular Anaesthesia and Intensive Care Medicine, M…. Hauptthemen laut MEDLINE: Pipecolic Acids, Thrombocytopenia, Heparin, Anticoagulants. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The anticoagulant argatroban, a direct thrombin inhibitor, serves as an alternative to heparin in patients with heparin-induced thrombocytopenia (HIT). However, its dose titration using activated partial thromboplastin time (aPTT) has limitations. We aimed to investigate whether ecarin clotting time (ECA-CT) correlates better with plasma argatroban concentrations than aPTT. METHODS: In this single-centre, observational study, 22 patients with HIT undergoing cardiac surgery and receiving argatroban anticoagulation were monitored over 5 days. The outcomes assessed were aPTT and ecarin clotting time (ECA-CT ClotPro®) values, plasma argatroban concentrations measured by a functional assay, and their correlations with each other. RESULTS: Ecarin clotting time demonstrated a strong correlation with plasma argatroban concentrations (r=0.881, 95% confidence interval [CI] 0.790-0.934, P 55 s, and was best described by a nonlinear approximation. Factor XII was the main independent driver of aPTT variability apart from argatroban concentration. Conversely, ecarin clotting time was independently affected by Factor II, X, and XI apart from argatroban. CONCLUSIONS: This study presents ECA-CT as a reliable point-of-care test for monitoring argatroban concentration in patients with HIT. aPTT demonstrated a pronounced inability to track argatroban concentrations, especially when aPTT was >55 s. These findings highlight the need to reconsider optimal anticoagulation targets when using argatroban.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pipecolic AcidsThrombocytopeniaHeparinAnticoagulantsDrug MonitoringAntithrombinsHumansArginineSulfonamidesProspective StudiesFemaleMaleAgedMiddle AgedPartial Thromboplastin TimeBlood Coagulation TestsBlood CoagulationAged, 80 and overEndopeptidases

Stichwörter der Autor:innen

activated partial thromboplastin timeargatrobanecarinecarin clotting timeheparin-induced thrombocytopeniaviscoelastic coagulation testing

Substanzen

argatrobanPipecolic AcidsArginineSulfonamidesHeparinAnticoagulantsecarinAntithrombinsEndopeptidases

Autor:innen und Institutionen

  • Department of Anaesthesia, Intensive Care Medicine and Pain Medicine, Division of Cardio-Thoracic-Vascular Anaesthesia and Intensive Care Medicine, Medical University of Vienna, Vienna, Austria.
  • University Clinic for Anaesthesia and Surgical Intensive Care, Kepler University Hospital, Linz, Austria.
  • Department of Anaesthesia, Intensive Care Medicine and Pain Medicine, Division of General Anaesthesia and Intensive Care Medicine, Medical University of Vienna, Vienna, Austria.
  • Institute of Medical Statistics, Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.
  • Department of Anaesthesia, Intensive Care Medicine and Pain Medicine, Division of Cardio-Thoracic-Vascular Anaesthesia and Intensive Care Medicine, Medical University of Vienna, Vienna, Austria. Electronic address: Barb…

Zitieren

APA

Schiferer, A., Schlömmer, C., Scheriau, G., Boryshchuk, D., Meyer, E. L., Benque, S., Holaubek, C., Wendel-Garcia, P., & Steinlechner, B. (2026). Ecarin-based coagulation monitoring of argatroban in patients with heparin-induced thrombocytopenia: a prospective observational study. British Journal of Anaesthesia. https://doi.org/10.1016/j.bja.2025.08.065

Vancouver

Schiferer A, Schlömmer C, Scheriau G, Boryshchuk D, Meyer EL, Benque S, et al. Ecarin-based coagulation monitoring of argatroban in patients with heparin-induced thrombocytopenia: a prospective observational study. British Journal of Anaesthesia. 2026. doi:10.1016/j.bja.2025.08.065

BibTeX
@article{Schiferer2026,
  author = {Schiferer, Arno and Schlömmer, Christine and Scheriau, Georg and Boryshchuk, Daniela and Meyer, Elias L and Benque, Sebastian and Holaubek, Caroline and Wendel-Garcia, Pedro and Steinlechner, Barbara},
  title = {Ecarin-based coagulation monitoring of argatroban in patients with heparin-induced thrombocytopenia: a prospective observational study},
  journal = {British Journal of Anaesthesia},
  year = {2026},
  doi = {10.1016/j.bja.2025.08.065}
}
Kostenlos starten →